Intravenous Tranexamic Acid Reduces Blood Loss and Transfusion Volume in Scoliosis Surgery for Spinal Muscular Atrophy: Results of a 20-Year Retrospective Analysis

Intravenous tranexamic acid (TXA) has been administered to reduce intraoperative blood loss in scoliosis surgery. However, the therapeutic effect of TXA on spinal muscular atrophy (SMA) scoliosis surgery is not well demonstrated. Therefore, this study aimed to assess the efficacy of intravenous TXA...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Shih-Hsiang, Lin, Sung-Yen, Wu, Meng-Huang, Tien, Yin-Chun, Jong, Yuh-Jyh, Liang, Wen-Chen, Lu, Yen-Mou, Shih, Chia-Lung, Lu, Cheng-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507662/
https://www.ncbi.nlm.nih.gov/pubmed/34639259
http://dx.doi.org/10.3390/ijerph18199959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507662/
https://www.ncbi.nlm.nih.gov/pubmed/34639259
http://dx.doi.org/10.3390/ijerph18199959

Ejemplares similares